One Case of Primary Hyperparathyroidism Diagnosed with Hypercalcemia after using Teriparatide
- Author:
Da Hee KIM
1
;
Ji Won KIM
;
Jun Hyung PARK
;
June Min SUNG
;
Hyoung Young KIM
;
Jung Min KIM
Author Information
1. Department of Internal Medicine, Sanggye Paik Hospital, Inje University College of Medicine, Seoul, Korea. jmkim.benaiah@paik.ac.kr
- Publication Type:Case Report
- Keywords:
Teriparatide;
Osteoporosis;
Primary hyperparathyroidism
- MeSH:
Adenoma;
Aged;
Diagnosis;
Female;
Fractures, Bone;
Humans;
Hypercalcemia;
Hyperparathyroidism, Primary;
Metabolism;
Osteogenesis;
Osteoporosis;
Teriparatide
- From:Journal of Korean Society of Osteoporosis
2015;13(1):55-59
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Primary hyperparathyroidism is a disease that causes hypercalcemia and abnormal bone metabolism due to an increase in parathyroid hormones, and the occurrence rate of bone fracturing is higher in patients with primary hyperparathyroidism. Parathyroid hormones have recently frequently been used as an osteogenesis catalyst treatment for osteoporosis in the elderly. This research study examined the case study that was experienced on the diagnosis and treatment of primary hyperparathyroidism caused by adenoma and extreme hypercalcemia that was discovered in menopausal women with bone fractures and extreme osteoporosis.
